nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
|
Chouchana, Laurent |
|
|
36 |
3 |
p. 483-488 |
artikel |
2 |
CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor
|
Zhou, Xue |
|
|
36 |
3 |
p. 455-465 |
artikel |
3 |
Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins
|
Kawada, Tomoyuki |
|
|
36 |
3 |
p. 569-570 |
artikel |
4 |
Efficacy and Safety of the Fixed-Dose Versus Variable-Dose of 4-PCC for Vitamin K Antagonist Reversal: A Comprehensive Systematic Review and Meta-Analysis
|
Mohammadi, Keyhan |
|
|
36 |
3 |
p. 533-546 |
artikel |
5 |
Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease
|
Muntner, Paul |
|
|
36 |
3 |
p. 475-481 |
artikel |
6 |
β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes—Adding Fuel to the Fire?
|
Ma, Xiurui |
|
|
36 |
3 |
p. 383-397 |
artikel |
7 |
Impact of Calcium Channel Blockers on Aspirin Reactivity in Patients with Coronary Artery Disease
|
Kodesh, Afek |
|
|
36 |
3 |
p. 467-473 |
artikel |
8 |
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
|
Castro, Pedro |
|
|
36 |
3 |
p. 547-560 |
artikel |
9 |
Letter to the Editor Regarding “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”
|
Xie, Yafei |
|
|
36 |
3 |
p. 571-572 |
artikel |
10 |
Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts
|
Weng, Liqing |
|
|
36 |
3 |
p. 413-424 |
artikel |
11 |
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure
|
Hofer, Felix |
|
|
36 |
3 |
p. 497-504 |
artikel |
12 |
Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis
|
Pei, Xinghua |
|
|
36 |
3 |
p. 399-412 |
artikel |
13 |
Rationale and Design of the ADIDAS Study: Association Between Dapagliflozin-Induced Improvement and Anemia in Heart Failure Patients
|
Zeng, Jianping |
|
|
36 |
3 |
p. 505-509 |
artikel |
14 |
Response to the Letter on “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”
|
Pitt, Bertram |
|
|
36 |
3 |
p. 573 |
artikel |
15 |
SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis
|
Zhang, Xiyu |
|
|
36 |
3 |
p. 437-447 |
artikel |
16 |
Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice
|
Zhang, Guangyan |
|
|
36 |
3 |
p. 425-436 |
artikel |
17 |
The Association between Multi-Vessel Coronary Artery Disease and High On-Aspirin Platelet Reactivity
|
Shiyovich, Arthur |
|
|
36 |
3 |
p. 449-454 |
artikel |
18 |
The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis
|
Itzhaki Ben Zadok, Osnat |
|
|
36 |
3 |
p. 489-496 |
artikel |
19 |
The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review
|
Wu, Qinchao |
|
|
36 |
3 |
p. 511-524 |
artikel |
20 |
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
|
Pitt, Bertram |
|
|
36 |
3 |
p. 561-567 |
artikel |
21 |
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
|
Allahham, Mahmoud |
|
|
36 |
3 |
p. 525-532 |
artikel |